Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor.
When studies on rheumatoid arthritis (RA) that were made many decades ago and could be considered "historical" in nature are analyzed in the context of recent observations, important insights on RA and on the function of rheumatoid factor (RF) become apparent. RF in the role of antibody to immune complexes (ICs) appears to be involved in activation of the complement system and in the production of chemotactic and inflammatory mediators, creating a condition that can be sustained and reinitiated. In the synovial cavity, a state of nonresolving inflammation is produced with the formation of citrullinated protein antigen-antibody complexes or other forms of ICs. This is followed by a second wave of IC production in the form of RF acting as antibody reactive with the initial ICs. Both of these processes are associated with complement consumption and production of inflammatory mediators. We present a model of an initiation phase of RA that might represent an example of repetitive formation of ICs and complement-mediated inflammation. Targeting therapy at this phase of RA to break the cycles of recurrent inflammation might be a novel approach to aid in further control of the disease.
The Scripps Research Institute, La Jolla, CA 92037 emtan@scripps.edu josef.smolen@wienkav.at.
Eng M
0000-0002-8711-3248
EM
Tan
Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, 1090 Vienna, Austria emtan@scripps.edu josef.smolen@wienkav.at.
Josef S
0000-0002-4302-8877
JS
Smolen
D000818:Animals; D000906:Antibodies / Q000378:metabolism; D000936:Antigen-Antibody Complex / Q000378:metabolism; D001172:Arthritis, Rheumatoid / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007249:Inflammation / Q000276:immunology; D008954:Models, Biological; D012217:Rheumatoid Factor / Q000378:metabolism*
D000906:Antibodies; D000936:Antigen-Antibody Complex; D012217:Rheumatoid Factor